Brighter outlook for Daiichi Sankyo on lower costs, one-off gains
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo has raised its net profit guidance for both the first half and full fiscal year, reflecting lower costs, reduced tax costs at its Ranbaxy subsidiary and one-off gains from real estate.